Intro

Last week, for the first time in U.S. history, federal regulators approved the sale of a birth control pill without a prescription.

Pam Belluck, a health and science correspondent for The Times, explains why, after decades of brutal battles over contraception, this decision played out so differently.

Guest: Pam Belluck, a health and science correspondent for The New York Times.

Background reading: 

• The F.D.A. approved a birth control pill to be sold without a prescription for the first time in the United States, a milestone that could significantly expand access to contraception.
• Here’s how women reacted to the news.

For more information on today’s episode, visit 

nytimes.com/thedaily

. Transcripts of each episode will be made available by the next workday.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.